PRR23D1: A Potential Drug Target and Biomarker (G100131608)

Target Name: PRR23D1

NCBI ID: G100131608

PRR23D1

PRR23D1: A Potential Drug Target and Biomarker

PRR23D1 is a protein that is expressed in the brain and has been identified as a potential drug target for the treatment of various neurological disorders, including Alzheimer's disease. The protein is a key component of the brain and is involved in the regulation of synaptic plasticity, which is the ability of the brain to change and adapt over time.

One of the unique aspects of PRR23D1 is its structure. It is a transmembrane protein, which means that it spans the cell membrane and is involved in the communication between different parts of the brain. This makes it an attractive target for drugs because it is relatively easy to target and because it is involved in a number of different brain functions.

In addition to its potential drug target properties, PRR23D1 is also a potential biomarker. This is because its levels can be easily measured and because it is a protein that is expressed in the brain, which makes it a good candidate for diagnostic tests.

The search for new treatments for Alzheimer's disease has been a major focus in recent years, and PRR23D1 is one of the many potential targets that is being investigated. Studies have shown that PRR23D1 is involved in the formation of beta-amyloid plaques, which are a hallmark of Alzheimer's disease, and that it may also be involved in the regulation of neurotransmitter release.

In addition to its potential therapeutic uses, PRR23D1 is also a valuable tool for researchers. Its structure and function have been extensively studied, which has led to a greater understanding of the underlying mechanisms of the brain. This information can be used to develop new treatments and to understand the underlying causes of other neurological disorders.

Overall, PRR23D1 is a protein that has the potential to be a drug target and biomarker for the treatment of Alzheimer's disease and other neurological disorders. Further research is needed to fully understand its role and to develop effective treatments.

Protein Name: Proline Rich 23 Domain Containing 1

The "PRR23D1 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about PRR23D1 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets